https://www.selleckchem.com/pr....oducts/etomoxir-na-s
Natalizumab is a very effective treatment of multiple sclerosis (MS). Failure is rare and should lead to consider some specific etiologies. The purpose of our study was to describe causes of subacute neurological events under natalizumab. Observational single-center retrospective study in the MS expert center of Lyon, France. any patient with definite MS who received at least three infusions of natalizumab between April 2007 and February 2017. Clinical data were extracted from the Lyon EDMUS/OFSEP database. Events of interest o
Like
Comment
Share
